Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients
Clinical trial NCT07191171 · RECRUITING
Trial details
- NCT number
- NCT07191171
- Sponsor
- University Hospital, Strasbourg, France
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-05
- Primary completion
- 2026-02-05
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.